Riskpilot← Back to searchSign inGet full accessJI Dental Lab AB
ABActiveOrg 5591357594Nedre Torekällgatan 12Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20171 employees
Revenue 2025
SEK 1,1M
+1578% vs 2024
EBITDA margin
21.6%
+2128% vs 2024
Equity ratio
12.5%
Financial strength
Net profit 2025
SEK 62K
+930% vs 2024
| Revenue | SEK 1,1M | +1578% |
| EBITDA | SEK 241K | +2128% |
| Net profit | SEK 62K | +930% |
| Total assets | SEK 882K | +19% |
| Equity | SEK 110K | +126% |
| Employees | 1 | — |
Legal name
JI Dental Lab AB
Org number
5591357594
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
28 november 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet ska vara att bedriva tandtekniskt laboratorium och arbeta med kronor, broar, implant, protes, ortodonti samt bettskenor och därmed förenlig verksamhet. Samt äga och förvalta värdepapper i dotter- och intressebolag samt därmed förenlig verksamhet.
Address
Nedre Torekällgatan 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 67 | 1 116 |
| Staff expenses | — | — | −0 | −37 | −320 |
| EBITDA | −8 | −8 | −3 | 11 | 241 |
| Depreciation & amort. | −0 | — | — | −7 | −111 |
| EBIT | −8 | −8 | −3 | 4 | 130 |
| Net financials | — | — | — | 3 | −52 |
| Profit before tax | −8 | −8 | −3 | 7 | 78 |
| Tax | −0 | — | — | −1 | −16 |
| Net profit | −8 | −8 | −3 | 6 | 62 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 941 | 48 | 38 | 740 | 882 |
| Equity | 34 | 26 | 43 | 49 | 110 |
| Long-term debt | 458 | 0 | — | 700 | 700 |
| Short-term debt | 449 | 23 | −5 | −8 | 71 |
| Total debt | 907 | 23 | −5 | 692 | 771 |
EBITDA margin
21.6%
This company
15.8%
Market median
+37% vs market
20212025
Equity ratio
12.5%
This company
38.2%
Market median
-67% vs market
20212025
Return on equity
55.8%
This company
18.4%
Market median
+203% vs market
20212025
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20212025
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
6.99×
This company
0.62×
Market median
-1027% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Deputy Board Member | 2023 | |
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JI Dental Lab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gabriel Varli | Board of Directors | 0 companies |
| Josef Izgin | Board of Directors | 0 companies |
| Cecilia Varli | Deputy Board Member | 0 companies |
| Diana Varli | Deputy Board Member | 0 companies |